Uploaded July 2026 | Updated September 2026, 1 week ago
Andy Gotshalk is a medical device executive with over 20 years’ experience currently serving as CEO of Neurologic Solutions Inc. Founded in 2016, Neurologic Solutions combines the specialized biomedical engineering skills and clinical insights to treating thousands of patients with medically refractory epilepsy.
On this episode of NeuroTalk, Andy Gotshalk joins us to discuss Neurologic Solutions' development of EpiScalp, a device that detects epilepsy in EEG data that looks completely normal - no seizure required.
He walks us through the science, the FDA pathway, and what it really takes to get this new tool to clinicians.
Andy Gotshalk is a medical device executive with over 20 years’ experience currently serving as CEO of Neurologic Solutions Inc. Founded in 2016, Neurologic Solutions combines the specialized biomedical engineering skills and clinical insights to treating thousands of patients with medically refractory epilepsy.
On this episode of NeuroTalk, Andy Gotshalk joins us to discuss Neurologic Solutions' development of EpiScalp, a device that detects epilepsy in EEG data that looks completely normal - no seizure required.
He walks us through the science, the FDA pathway, and what it really takes to get this new tool to clinicians.
